Stockscreener 앱 받기
0.5222
0.44%
0.0023
시간 외 거래:
.50
-0.0222
-4.25%
전일 마감가:
$0.5199
열려 있는:
$0.5361
하루 거래량:
183.30K
Relative Volume:
0.64
시가총액:
$4.82M
수익:
$11.26M
순이익/손실:
$-3.09M
주가수익비율:
-1.3026
EPS:
-0.4009
순현금흐름:
$-1.49M
1주 성능:
-14.49%
1개월 성능:
-12.98%
6개월 성능:
-64.72%
1년 성능:
-78.24%
1일 변동 폭
$0.4952
$0.5534
1주일 범위
$0.4794
$0.6166
52주 변동 폭
$0.4794
$2.8899
Nexgel Inc Stock (NXGL) Company Profile
명칭
Nexgel Inc
전화
215 702-8550
주소
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.5222 | 4.80M | 11.26M | -3.09M | -1.49M | -0.4009 |
ISRG
Intuitive Surgical Inc
|
405.97 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.19 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.61 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.61 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.43 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Nexgel Inc 주식(NXGL)의 최신 뉴스
NexGel, Inc. Actuals & Estimates (NASDAQ:NXGL) - TradingView
NXGL Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Nexgel Inc For: 23 June By Investing.com - Investing.com Nigeria
Nexgel CEO Adam R. Levy sells $6,519 in company stock - Investing.com
Nexgel CEO Adam R. Levy sells $6,519 in company stock By Investing.com - Investing.com Canada
Insider sale: NEXGEL (NXGL) CEO sells 11,000 common shares - Stock Titan
Nexgel Inc (NXGLW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nexgel Inc (NXGLW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nexgel Inc (NXGLW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nexgel Inc (NXGLW) Institutional Confidence - TradingKey
Nexgel Inc (NXGLW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Number of shareholders of NexGel, Inc – NASDAQ:NXGLW - TradingView
NexGel Updates Investor Presentation Under Regulation FD Disclosure - TipRanks
Nexgel Inc (NXGL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nexgel Inc (NXGL) Institutional Confidence - TradingKey
NXGL: Expanded regenerative medicine portfolio and direct sales force set stage for rapid growth - TradingView
Nexgel Inc (NXGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nexgel Inc (NXGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nexgel Inc (NXGL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nexgel Inc (NXGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NexGel begins using new investor presentation under Regulation FD - TradingView
NexGel (NASDAQ: NXGL) furnishes updated investor presentation under Reg FD - Stock Titan
Nexgel Inc (NXGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nexgel Inc (NXGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nexgel Inc (NXGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nexgel Inc (NXGLW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nexgel Inc (NXGLW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nexgel Inc (NXGLW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nexgel CEO Adam Levy sells $1,840 in shares By Investing.com - Investing.com India
Nexgel CEO Adam Levy sells $1,840 in shares - Investing.com
NEXGEL (NXGL) CEO sells 3,000 shares, retains 333,692-holding stake - Stock Titan
Nexgel Inc (NXGLW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nexgel CEO Adam Levy sells $3,421 of common stock By Investing.com - Investing.com Nigeria
Nexgel CEO Adam Levy sells $3,421 of common stock - Investing.com
NEXGEL (NXGL) CEO Adam Levy sells 6,000 common shares but keeps large stake - Stock Titan
Large potential dilution as NexGel (NASDAQ: NXGL) seeks note conversion, Nevada move and reverse split - Stock Titan
NEXGEL Expands Investor Outreach With MicroCap Conference Appearance - MyChesCo
NXGL Q1 2026 Earnings: EPS Misses Estimates by 54% Despite Positive Stock ReactionProfitability Analysis - newsline.com
NexGel Inc Warrant (NXGLW) Slides Marginally, Testing Key Support at $0.04Volume Nodes - newsline.com
NexGel stock (US65340W1027): Micro-cap hydrogel specialist in focus after recent volatility - Ad-hoc-news.de
NexGel Inc (NXGL) Weakens by 4.43% as Shares Approach Critical $0.53 Support LevelNHNL Divergence - newsline.com
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th -18th - The Manila Times
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th - GlobeNewswire
NEXGEL heads to Las Vegas for Planet MicroCap 2026 conference - Stock Titan
Nexgel CEO Adam Levy sells $1,171 in company stock - Investing.com UK
Nexgel CEO Adam Levy sells $1,171 in company stock By Investing.com - Investing.com Australia
NXGL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NEXGEL (NXGL) CEO Adam R. Levy sells 2,000 common shares at $0.5859 - Stock Titan
New Celularity (NASDAQ: CELU) CCO to drive cenplacel-L and Lifebank growth - Stock Titan
Celularity outlines placenta cell therapy push to extend health span - Stock Titan
NXGL Q1 2026 Earnings: EPS Misses Estimates as Company Faces Operational HeadwindsAdjusted Earnings Analysis - newsline.com
Nexgel Inc (NXGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.52%
자본화:
|
볼륨(24시간):